Anavex Life Sciences Corp reports results for the quarter ended in March - Earnings Summary

Anavex Life Sciences

09/05/2023 14:33

* Anavex Life Sciences Corp  AVXL.OQ  reported a quarterly
adjusted loss of 17 cents​​ per share for the quarter ended in
March. The mean expectation of three analysts for the quarter
was for a loss of 19 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Anavex Life Sciences Corp's reported EPS for the quarter
was a
loss of 17 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Anavex Life Sciences Corp shares had fallen by 1.9% this
quarter and lost 9.2% so far this year.
    * The company reported a quarterly loss of $13.11 million.
    * Wall Street's median 12-month price target for Anavex Life
Sciences Corp is $47.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.19          -0.17          Beat
 Dec. 31 2022      -0.19          -0.17          Beat
 Sep. 30 2022      -0.16          -0.18          Missed
 Jun. 30 2022      -0.15          -0.16          Missed